表紙:分子診断の世界市場(2021年~2027年)
市場調査レポート
商品コード
1025324

分子診断の世界市場(2021年~2027年)

Molecular Diagnostics Market 2021-2027

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
分子診断の世界市場(2021年~2027年)
出版日: 2021年06月22日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子診断市場は、予測期間中に9.9%の大幅なCAGRで成長することが見込まれています。この市場の成長を促進する主な要因としては、世界中でAIDSやCOVID-19などの感染症の流行が増加していることが挙げられます。また、癌も生命を脅かす疾患の一つであり、市場の成長を支えています。しかし、分子診断の機器が高価であることが、世界の分子診断市場の成長を抑制しています。

COVID-19の普及は、世界の分子診断市場に有利な成長をもたらしました。しかし、がんやエイズを含む他の主要な疾患の治療に使われないため、他の用途の市場は縮小しています。

世界の分子診断市場は、技術、製品、用途に基づいて分類されています。技術に基づいて、市場はPCR、ISH、DNAマイクロアレイ、NSG、等温核酸増幅、その他の技術に分けられます。製品別では、検査機器、診断試薬・キット、サービス・ソフトウェアに分類されています。用途別では、感染症、がん、CVD、遺伝子検査、神経疾患、その他に分類されています。世界の分子診断市場では、プロテオミクスやゲノミクス分野での利用拡大を背景に、PCR分野が大きなシェアを占めています。例えば、COVID-19を検出するためのRT-PCRテストは、この分野の先進技術であるqRT-PCRテストの増加により、市場に大きな成長をもたらしました。

当レポートでは分子診断の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、技術・製品・用途・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の開発
  • 重要な戦略分析
  • キープレーヤーに対するCOVID-19の影響

第4章 市場の決定要因

  • 動機
  • 抑制要因
  • 市場機会

第5章 市場細分化

  • 技術別
    • ポリメラーゼ連鎖反応(PCR)
    • インサイチュハイブリダイゼーション(ISH)
    • DNAマイクロアレイ
    • 次世代シーケンシング(NGS)
    • 等温核酸増幅
    • その他
  • 製品別
    • 検査機器
    • 診断試薬とキット
    • サービスとソフトウェア
  • 用途別
    • 感染症(COVID-19を含む)
    • 心血管疾患(CVD)
    • 遺伝子検査
    • 神経疾患
    • その他

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • AltheaDX, Inc.
  • AutoGenomics, Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Co.
  • Biocartis N.V.
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • CareDX, Inc.
  • Danaher Corp.
  • ELITech Group
  • Exact Science Corp.
  • F. Hoffmann-La Roche, Ltd.
  • Genetic Technologies, Ltd.
  • GenMark Diagnostics, Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • HTG Molecular Diagnostics, Inc.
  • MDxHealth Group
  • Merck KGaA
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN GmbH
  • Sequenom, Inc.
  • Siemens Healthcare Pvt. Ltd.
  • Source BioScience, Ltd.
  • Thermo Fisher Scientific, Inc.
  • Veracyte, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 2. GLOBAL PCRMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ISHMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL DNA MICROARRAYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL NSGMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATIONMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL OTHER TECHNOLOGIESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 9. GLOBAL TESTING EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL DIAGNOSTIC REAGENTS AND KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL SERVICES & SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 13. GLOBAL MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL MOLECULAR DIAGNOSTICS FOR CANCERMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL MOLECULAR DIAGNOSTIC FOR CVDMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL MOLECULAR DIAGNOSTICS FORGENETIC TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBALMOLECULAR DIAGNOSTICS FORNEUROLOGICAL DISEASESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBALMOLECULAR DIAGNOSTICS for OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN MOLECULAR DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 24. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 26. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 27. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 28. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2021-2027 (%)
  • 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
  • 5. GLOBAL PCRMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL ISHMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL DNA MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL NSG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBAL OTHER TECHNOLOGIES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 12. GLOBAL TESTING EQUIPMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL DIAGNOSTIC REAGENTS AND KITS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL SERVICES & SOFTWARE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATIONS, 2020 VS 2027 (%)
  • 16. GLOBALMOLECULAR DIAGNOSTICS FORINFECTIOUS DISEASESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 17. GLOBALMOLECULAR DIAGNOSTICS FOR CANCERMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 18. GLOBALMOLECULAR DIAGNOSTICS FOR CVDMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 19. GLOBALMOLECULAR DIAGNOSTICS FOR GENETIC TESTINGMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 20. GLOBALMOLECULAR DIAGNOSTICS FOR NEUROLOGICAL DISEASES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 21. GLOBALMOLECULAR DIAGNOSTICS FOR OTHER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 22. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 23. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 24. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 25. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 26. EUROPEAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 27. UK MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 28. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 29. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 30. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 31. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 32. ROE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 33. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 34. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 35. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 36. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 37. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 38. REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 39. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2023736

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), DNA Microarray, Next-Generation Sequencing (NGS), Isothermal Nucleic Acid Amplification, and Other Technologies), By Product(Testing Equipment, Diagnostic Reagents & Kits, and Services & Software), By Applications (Infectious Diseases, Cancer, Cardiovascular Disease (CVD), Genetic Testing, Neurological Disease, and Other) Forecast Period (2021-2027)

The global molecular diagnostics market is anticipated to grow at a substantial CAGR of 9.9% during the forecast period. The major factor fueling the growth of the market includes the rise in the prevalence of infectious diseases like AIDS and COVID-19 across the globe. Cancer is another life-threatening disease that is giving support to market growth. However, the expensive instruments of molecular diagnostics are restraining the growth of the global molecular diagnostics market.

The spread of COVID-19 had given lucrative growth to the global molecular diagnostics market. However, the market of other applications had reduced due to the sideline of the treatment of other major diseases including cancer and AIDS.

The global molecular diagnostics market is segmented based on technology, product, and applications. Based on the technology, the market is segmented into PCR, ISH, DNA microarray, NSG, isothermal nucleic acid amplification, and other technologies. Based on the product, the market is segmented into testing equipment, diagnostic reagents & kits, and services & software. Apart from this, by applications, the market is segmented into infectious diseases, cancer, CVD, genetic testing, neurological disease, and others. The PCR segment occupies the major share in the global molecular diagnostics market attributing to its increasing use in proteomics and genomics. For instance, the increased RT-PCR test to detect COVID-19 had given significant growth to the market; the qRT-PCR test is the advanced technology in this field.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the major share in the global bioreactors market. However, emerging countries like India and China of Asia Pacific will show the fastest growth in the market.

The companies engaged in molecular diagnostics provide reagent kits and testing equipment for molecular diagnostic tests. The market players also provide molecular diagnostic services for the treatment and diagnosis of infectious diseases and cancer. The key players in the molecular diagnostics market include Becton Dickinson and Co., Abbott Laboratories, Inc., bioMerieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Nanopore Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches with innovation in current models, to stay competitive in the market. For instance, Hologic, Inc. had acquired Biotheranostics Inc. (US) in January 2021 to expand its product portfolio. Roche Diagnostics had acquired Stratos Genomics (US) in May 2020 to support the development of its nanopore technology and take access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). Abbott Laboratories had launched a new product the ID NOW PoC testing system in March 2020.

Research Methodology

The market study of the global industrial fastenersmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, researchpapers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Industrial FastenersMarket Research and Analysis by Product Type

Global Industrial FastenersMarket Research and Analysis by Material

Global Industrial FastenersMarket Research and Analysis by End-user

The Report Covers

Comprehensive research methodology of the globalindustrial fastenersmarket.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global industrial fastenersmarket.

Insights about market determinants that are stimulating the global industrial fastenersmarket.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Molecular Diagnostics Market
  • Recovery Scenario of Global Molecular Diagnostics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Molecular Diagnostics Market by Technology
    • 5.1.1. Polymerase Chain Reaction (PCR)
    • 5.1.2. In Situ Hybridization (ISH)
    • 5.1.3. DNA Microarray
    • 5.1.4. Next-Generation Sequencing (NGS)
    • 5.1.5. Isothermal Nucleic Acid Amplification
    • 5.1.6. Other Technologies
  • 5.2. Global Molecular Diagnostics Market by Product
    • 5.2.1. Testing Instruments
    • 5.2.2. Diagnostic Reagents and Kits
    • 5.2.3. Services & Software
  • 5.3. Global Molecular Diagnostics Market by Applications
    • 5.3.1. Infectious Diseases (including COVID-19)
    • 5.3.2. Cancer
    • 5.3.3. Cardiovascular Disease (CVD)
    • 5.3.4. Genetic Testing
    • 5.3.5. Neurological Disease
    • 5.3.6. Other

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Agilent Technologies, Inc.
  • 7.3. AltheaDX, Inc.
  • 7.4. AutoGenomics, Inc.
  • 7.5. Beckman Coulter, Inc.
  • 7.6. Becton Dickinson and Co.
  • 7.7. Biocartis N.V.
  • 7.8. bioMerieux S.A.
  • 7.9. Bio-Rad Laboratories, Inc.
  • 7.10. CareDX, Inc.
  • 7.11. Danaher Corp.
  • 7.12. ELITech Group
  • 7.13. Exact Science Corp.
  • 7.14. F. Hoffmann-La Roche, Ltd.
  • 7.15. Genetic Technologies, Ltd.
  • 7.16. GenMark Diagnostics, Inc.
  • 7.17. Grifols, S.A.
  • 7.18. Hologic, Inc.
  • 7.19. HTG Molecular Diagnostics, Inc.
  • 7.20. MDxHealth Group
  • 7.21. Merck KGaA
  • 7.22. Oxford Nanopore Technologies Ltd.
  • 7.23. QIAGEN GmbH
  • 7.24. Sequenom, Inc.
  • 7.25. Siemens Healthcare Pvt. Ltd.
  • 7.26. Source BioScience, Ltd.
  • 7.27. Thermo Fisher Scientific, Inc.
  • 7.28. Veracyte, Inc.